21st International Conference on Emergency Medicine 2022

14 – 19 June

Hybrid Conference I Melbourne Convention and Exhibition Centre

21st International Conference on Emergency Medicine

14 – 19 June 2022

Hybrid Conference
Melbourne Convention and Exhibition Centre

21st International Conference on Emergency Medicine 2022

14 – 19 June

Hybrid Conference I Melbourne Convention and Exhibition Centre
07:00 – 08:15


Innovative advancement in the assessment and evaluation of mTBI with biomarker-based testing

Join us as we explore an innovative technique for objective assessment of suspected mild traumatic brain injury (mTBI) in the ED using blood based biomarkers. We will also explore how they could be utilised to improve patient outcomes, patient flow in the ED and their potential place in clinical pathways – with Dr Gary Mitchell from Queensland Health.

Chair: Dr Jaime Marino, Associate Director Medical Affairs, Abbott Core Laboratories 

Speaker: Dr Gary Mitchell, Queensland Health on:

Innovative technique for objective assessment of suspected mild traumatic brain injury (mTBI) in the ED using biomarkers  

Advancements in Brain Injury Evaluation in the ED: How TBI biomarkers could change clinical evaluation of mTBI or How TBI Biomarkers could change TBI evaluation in the clinical setting 


Chair: Chris Davlantes 

Blurb about this Presenter

Chair: Dr Jaime Marino



Associate Director Medical Affairs, Abbott

Dr. Jaime Marino is an Associate Director Medical Affairs at Abbott Core Laboratories. He is a physician with a Masters in Business Administration focused on Healthcare Administration and experience in pharmaceutical  and diagnostic research. He has a tenure of 9 years at Abbott in Clinical and Medical Affairs.

Dr. Marino has led clinical studies for regulatory submission in a wide variety of disease states and also companion diagnostics studies for Phase II-IV in the US and also Outside of the US. He has led  global research studies with companies and academic institutions in the neuro early research and discovery space. His work has allowed the filing of over 30 patents and included as inventor in over 8 patent applications. He has co-author several TBI biomarker publications.

Dr. Marino has led research studies that supported regulatory submissions to the FDA for Abbott Point of Care and Abbott Core Laboratory and breakthrough designations for TBI related biomarker claims. He has been invited as speaker and participant in TBI discussions with companies and academic institutions.

Dr. Marino has worked with TRACK-TBI, the DOD , and advocacy groups to make headway to new technologies to help improve the health care of patients that suffer traumatic brain injuries.  

Chair: Dr Gary Mitchell


Current Appointments-

  • Staff Specialist – Royal Brisbane and Women’s Hospital Emergency and Trauma Centre
  • Senior Lecturer- University of Queensland
  • Clinical Appointment- Jamieson Trauma Institute
  • Queensland Rugby Union/ Australian Rugby Union – Match-day/Team Doctor


After completing undergraduate medical training at Queens University Belfast and after working in the UK NHS as a Junior Doctor, he moved to Brisbane and trained as a Specialist in Emergency Medicine. After completing his specialist training in emergency medicine, he then spent a year in Canada at the University of Calgary completing a fellowship in Pre-hospital and Disaster medicine.

He has an interest in TBI, specifically in concussion assessment and management. He chairs the JTI TBI advisory committee and sits on the Qld statewide brain and spinal cord injury committee. He is involved in multiple local, national and international trials on TBI ranging from clinical biomarkers, innovative technology, imaging and interventions.

Having played rugby union for Ireland and Ulster at various age-grades and club rugby in Ireland, Canada and Australia, he has stayed involved with the sport by working with numerous teams from grassroots to the international level and is passionate about translating professional concussion care to grassroots athletes.



As a leading global medical technology, diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.

With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the centre of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

We embrace a culture of respect, transparency, integrity and diversity.

Vyaire Medical Inc. is a global company, headquartered in suburban Chicago, focused exclusively on supporting breathing through every stage of life. Established from legacy brands with a 65-year history of pioneering breathing technology, the company’s portfolio of integrated solutions is designed to enable, enhance, and extend lives.

At Vyaire, our team of 4000, pledges to advance innovation and evolve what’s possible to ensure every breath is taken to its fullest. Vyaire’s products are available in more than 100 countries and are recognized, trusted, and preferred by specialists throughout the respiratory community worldwide.

Vyaire has a long and proud history with emergency care throughout Australia and beyond. As the home of legacy brands including Vital Signs, AirLife, enFlow, GreenLight, bellavista, and many more, we are your trusted partner every step in delivering emergency care.

Come speak to Vyaire to learn more about our innovative solutions in ventilation and respiratory care, and blood and fluid management in the ED.


Insert Bio


Face placeholder

Insert Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.